Specialty patients in Los Angeles could be forced to use mail-order, advocates say
NEW YORK — Thousands of patients in Los Angeles with serious, chronic diseases could soon find themselves unable to get their drugs from community pharmacies, advocates for the pharmacies said.
Over the past several weeks, specialty pharmacy patients — most of them HIV patients, as well as those with cancer, autoimmune conditions and other disease states — covered by Anthem Blue Cross have received letters from the health insurer stating that starting Jan. 1, 2013, their drugs will only be covered if they obtain them through mail order from CuraScript, a mail-order pharmacy owned by pharmacy benefit manager Express Scripts, while those who continue to use retail pharmacies will have to shoulder the full cost of their drugs, antitrust lawyer David Balto told Drug Store News. Balto, who was a policy director of the Federal Trade Commission during the Clinton administration and brought some of the first cases against PBMs and often represents community pharmacies, began advocating for the Los Angeles pharmacies after several of them contacted him when their patients began receiving the letters.
"As part of our efforts to enhance healthcare affordability, Anthem Blue Cross has contracted with a vendor to purchase certain high-cost specialty drugs in bulk and provide them via home delivery to our members," Anthem spokesman Darrel Ng told Drug Store News. "This action, among many others undertaken by our company, helps moderate healthcare costs. We think this is important at a time when businesses and individuals are deciding whether they can afford to continue to maintain health benefits coverage. In addition, studies suggest that home delivery of prescription drugs can improve medication compliance and a recent study has even shown enhanced health outcomes."
Express Scripts declined to comment further.
While no lawsuit has been filed, and Balto said he and the pharmacies for which he is advocating were exploring options and examining whether Anthem’s decision violates any anti-trust laws, the dispute is an example of the often testy relationship between pharmacy retailers — particularly independents — and PBMs. PBMs say mail-order represents a more cost-effective and efficient way of getting drugs to patients and say mail-order saves customers money on prescriptions compared with brick-and-mortar retailers. For pharmacy retailers, however, not only does use of mail-order cut into their business, it also means that patients don’t have access to the kind of face-to-face interaction that the retailers say many of them need and tout as their key advantage. PBMs have also emphasized that they offer 24-hour access by phone to pharmacists and nurses, including pharmacists whose entire focus is on a specific condition such as HIV and who know all the drugs, interactions and other issues involved. But Balto said a "disinterested voice at the end of a 1-800 number" isn’t enough.
"This is far more than just dispensing drugs," Balto told Drug Store News. "People will lose those services, and that will threaten the continuity of care they receive."
Balto said that while mail-order may be appropriate for some patients, it’s not for patients with complex, chronic conditions like HIV. Specialty pharmacists themselves also say their role goes far beyond dispensing.
"Putting a label on the bottle — that’s the least of what we do," Marva Brannum, a clinical pharmacist at Edwin’s Prescription Pharmacy, one of the pharmacy’s Balto is representing, told Drug Store News. "The care is actually part of the prescription."
Brannum, who has worked with HIV and AIDS patients for nearly 30 years, said working with patients also included knowing the psychological and social issues involved with their disease states, fitting medications into their lives and being able to alter their therapies quickly when needed. For example, some patients are homeless or transient and don’t have the option of receiving three-month supplies of drugs through the mail or are living in a situation where other people don’t know about their status. Working with patients directly also allows pharmacists to know about drug interactions. "We are an extension of the patient’s clinical team," Brannum said.
For Brannum, it’s not just knowing the drugs the patient uses, but knowing the patient. "The most intricate part that leads to quality outcomes and leads to decreased costs for us is knowing the patient in total," Brannum said.
Since legal professionals, carrying on with to understand, increasing the abilities along with remaining operating can be a significant component of having a profitable legal career. Guides could perform a vital component in your skilled improvement. wyotriallawyer
well totally agree with you on the patient concerns and i think government has to think something about it. Surprise Locksmith
Nice post, Thanks.
It is not good news that patients could lose access to needed services. Massive unfortunate situation will occur if a lot of patients have to buy their drugs by full cost when needed. We should about the new policies. Advocates are working for the pharmacies told the future fact to alert us. Inexpensive or reliable lawyer is now rare around us. Thanks for the information I read in the above post. But I can say some attorneys are really working well for us. By the help of a personal injury attorney Tacoma you can resist with your unfortunate situation that comes suddenly.
The patients will therefore not be benefited from the policies introduced. Since Express scripts will only be the provider of ailments and medicines for the patients problems, with the total restrictions on the medicine usage to pay full costs if not dealt with the above company. Balto has expressed the step as valid and will work to full extent. So with these new policies many are just bringing forward their hands to deal with the company to handle the problem directly means carrying large bulks of medicines for the hospitals.Virginia injury attorneys
NABP implements nationwide effort to oversee compounding pharmacies
MOUNT PROSPECT, Ill. — A national group representing state boards of pharmacy has announced its support for efforts to strengthen regulations on compounding pharmacies.
The National Association of Boards of Pharmacy said Wednesday that it would implement a four-part action plan centered around inspection of compounding pharmacies and sharing data from the inspections among boards of pharmacies around the country.
The announcement comes in the wake of a nationwide meningitis outbreak linked to contaminated injectable steroid drugs prepared at the New England Compounding Center, in Framingham, Mass., which had sickened 590 and led to 37 deaths in 19 states as of Monday, according to the Centers for Disease Control and Prevention. The outbreak has led to calls by legislators and the Food and Drug Administration for stronger regulations of pharmacy compounding, particularly after an FDA inspection of the NECC found widespread contamination and unsanitary conditions.
The NABP’s four-part plan consists of sharing a list of compounding pharmacies provided by the Iowa Board of Pharmacy with other NABP member boards and coordinating the collection of information on them; the second part involves implementing the inspection program to ensure they are doing business according to regulations and taking action against pharmacies that refuse inspection; the third part includes collection and maintaining of data on the pharmacies and storing it in an electronic profile; the fourth part involves training board of pharmacy inspectors and compliance officers, as well as cooperation with the FDA and legislators.
"Creating an information sharing network of verifiable data on compounding pharmacies, including information on the scope of operations, results of the Iowa inspection program and any disciplinary actions will provide a vital resource to support the boards’ regulatory efforts in this area," NABP president Michael Burleson said. "The network will be made available at no cost to boards for use in making licensure and registration determinations for pharmacies and may also help to identify pharmacies whose operations are more akin to manufacturing than compounding."
Third party inspections are gladly available in country like India and China. The quality and professionalism are all extremely changeable. Meet the local director of the company you select, and also attempt to meet the inspector. Third Party Inspection in India
That's the motive for a final pre-shipment Inspection, you or your excellence inspection team visit the factory site and verify the quality of the over products and their wrapping. A final pre-shipment inspection for clear reasons takes place at the end of or close to the end of the manufacturing process. pre shipment inspection india approvals
FDA accepts application for Takeda, Lundbeck antidepressant
DEERFIELD, Ill. — The Food and Drug Administration has accepted a regulatory approval application from Takeda and Lundbeck for an experimental drug to treat depression, the companies said Wednesday.
The FDA will review the companies’ application for vortioxetine for the treatment of major depressive disorder in adults. The agency expects to finish reviewing the application by Oct. 2, 2013.
The application includes data from seven studies that included more than 7,500 patients ages 18 to 88 years. The companies have proposed marketing the drug under the name Brintellix if it wins approval.
No comments found